Lustberg M et al. (2024) [2] conducted a pilot randomized controlled trial (RCT) with nanoemulsion curcumin (NEC) for alleviating aromatase inhibitor-induced arthropathy (AIIA) in postmenopausal women with ER-positive breast cancer. This evidence concerns the gene CYP19A1 and arthropathy.